PanCryos' Seed Round

PanCryos raised a round of funding on , . Investors include Novo A/S.

PanCryos is a prospective spin out company arising from DanStem, University of Copenhagen, aiming to develop a next generation stem cell derived allogenic cell therapy (PanINSULA) for type 1 diabetes,…

Articles about PanCryos' Seed Round: